Teicoplanin: an alternative drug for the treatment of COVID-19?
Sophie Alexandra Baron, Christian Devaux, Philippe Colson, Didier Raoult, Jean‐Marc Rolain
Topics & Concepts
TeicoplaninRitonavirPneumoniaMiddle East respiratory syndrome coronavirusLopinavirMedicineRibavirinVirologyCoronavirusAntibioticsDrug repositioningOutbreakDrugTransmission (telecommunications)Coronavirus disease 2019 (COVID-19)VirusStaphylococcus aureusMicrobiologyPharmacologyBiologyVancomycinViral loadInternal medicineDiseaseInfectious disease (medical specialty)GeneticsBacteriaElectrical engineeringEngineeringHepatitis C virusAntiretroviral therapyCOVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 ResearchPharmacological Receptor Mechanisms and Effects